Mather Group’s NeoGenomics NEO Stock Holding History

Mather Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-305	Closed	-$2.35K	–	1290
2025 Q3	$2.35K	Buy	+305	New	+$2.14K	﹤0.01%	1516
2024 Q3	–	Sell	-50	Closed	-$786	–	2021
2024 Q2	$786	Buy	+50	New	+$709	﹤0.01%	2021

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Mather Group's NEO Position: Q4 2025 in Review

Mather Group sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 305 shares — an estimated $2.35K sold.

Mather Group first reported a position in NEO in Q2 2024 and held it in 2 quarters. The position peaked at $2.35K in Q3 2025. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

Mather Group reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
Mather Group sold 305 NeoGenomics shares in Q4 2025, an estimated $2.35K.
Mather Group first reported a position in NeoGenomics in Q2 2024 and held it in 2 quarters.
Mather Group's NeoGenomics position peaked at $2.35K in Q3 2025.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Mather Group's 13F filing for Q4 2025, filed 13 Jan 2026.